The Dermatology Digest Podcast Exclusives

Dr. Rick Fried offers advice and discusses strategies for effectively managing the difficult parents of acne patients.

Dr. Rick Fried offers advice and discusses strategies for effectively connecting with and treating the emotional or noncommunicative acne patient.

In his latest rant, Dr. Ted Rosen says giving advising students to “follow your passion” is not only cliche, it could be a setup for failure.

In his latest rant, Dr. Ted Rosen admits he's bad at delegating... but he's working on it (and finding the rewards can be sweet).

Dr. Nicholas Brownstone discusses the evaluation process and building rapport with dermatology patients who present with delusions of parasitosis.

Daniel Butler, MD, discusses the use of Dupilumab for treating Grover disease and possible pathophysiology insights based on a recent case series in JAMA Dermatology .

In the final episode of our podcast series on BPDCN, dermatologist and dermatopathologist Dr. Whitney High discusses disease prognosis and offers guidance for referring patients to a hematologist oncologist. This is part 3 in The Dermatology Digest’ s 3-part educational podcast series, sponsored by Stemline, which provides an overview of BPDCN, including the dermatologist’s important role in diagn...

Sheila Friedlander, Scripps Clinic, San Diego, to discuss recent developments in tinea capitis, including epidemiology, diagnosis, and treatment.

Dr. George Cohen discusses misconceptions about skin cancer in skin of color as well as increased risk factors and lesion recognition.

Dr. James Treat discusses current and future monoclonal antibodies for atopic dermatitis treatment, including dupilumab, tralokinumab, and lebrikizumab.

Dr. Brent Moody discusses non-medical switching and formulary exclusions, how they affect both dermatology patients and practices, and what the dermatologist can do to advocate for their patients.

Dr. Madelaine Feldman discusses non-medical switching in the dermatology and rheumatology specialties, including the role of pharmacy benefit managers, and the Safe Step Act.

Steven Newmark, Director of Policy, Chief Legal Officer of the Global Healthy Living Foundation (GHLF), discusses the Foundation’s position on non-medical switching, the repeal process, and the dermatologist’s supporting role.

The zombie apocalypse meets the dermatology practice in Dr. Ted Rosen's talk this month about lessons gleaned from his favorite genre, including strength in unity, identifying the real enemy, and despite it all, finding ways to have fun.

In part 2 of this 3-part series, Dr. Whitney High details the BPDCN diagnosis process, including the triad of proteins that may indicate a positive diagnosis, as well as common misdiagnoses.

From the 2021 Maui Derm Connect Meeting, Dr. Ilona Frieden offers several tips and tricks to minimize pain local injection pain for the pediatric patient.

PODCAST Ted Rants #3 Listen Up! Hear Here! Ted Talks but sometimes Ted Rants. This time? He sounds off on the (nearly) lost skill of taking a good patient history at the outset of the diagnostic process.

From the 2021 Maui Derm Connect Meeting, Dr. Pearl Grimes reviews the pathogenesis of dyspigmentation, including hyperpigmentation and vitiligo.

Dr. John Barbieri discusses recent research that examines the dermatologist’s possible role as primary care physician for some patients.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, yet aggressive and challenging-to-diagnose blood cancer that nearly always presents with cutaneous involvement. In this first episode of The Dermatology Digest ’s 3-part educational podcast series, dermatologist and dermatopathologist Dr. Whitney High discusses BPDCN patient demographics and the characteristics of cutaneous lesions.

In our cannabinoid series that examines current dermatologic pros and cons, Dr. Shawn Kwatra is cautiously optimistic, but advises to proceed with caution.

In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman talks CBD vs medical cannabis, dispensaries, and navigating state regulations.

In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman discusses the potential for CBD in dermatology, the science, and current clinical trial programs.

The recent winter storm in Texas has Ted Rosen, MD, talking adversity, resilience and hope in medicine and in life.

Dr. Mayar Mohajer discusses data he presented at IDWeek 2020 that examines what happens to COVID rates of infection when healthcare workers wear face shields and masks together.